Cholestyramine and Demadex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cholestyramine (cholestyramine) and Demadex (torsemide). Common drug interactions include thrombosis among females and hyperlipidaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Cholestyramine and Demadex. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Cholestyramine?

Cholestyramine has active ingredients of cholestyramine. It is often used in diarrhea. eHealthMe is studying from 9,893 Cholestyramine users. Check the latest studies of Cholestyramine.

What is Demadex?

Demadex has active ingredients of torsemide. It is often used in heart failure. eHealthMe is studying from 5,358 Demadex users. Check the latest studies of Demadex.

On Jul, 11, 2026

15 people who take Cholestyramine and Demadex together, and have interactions are studied.

Cholestyramine and Demadex drug interactions.

What are the common drug interactions of Cholestyramine and Demadex, by gender? *:

female:

Thrombosis (formation of a blood clot inside a blood vessel)
Anaphylactic reaction (serious allergic reaction)
Infusion related reaction

male:

Hyperlipidaemia (presence of excess lipids in the blood)
Abscess jaw (tooth abscess or root abscess)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Bacteraemia (presence of bacteria in the blood)
Benign prostatic hyperplasia (benign enlargement of the prostate)
Bicytopenia (two parameters from the full blood count are low, the term bicytopenia can be used)
Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
Calcium metabolism disorder (occur when the body has too little or too much calcium)
Cardiac failure congestive
Cardiomegaly (increased size of heart than normal)

What are the common drug interactions of Cholestyramine and Demadex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Hyperlipidaemia (presence of excess lipids in the blood)
Weight increased
Atelectasis (partial or complete collapse of the lung)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Bacteraemia (presence of bacteria in the blood)
Benign prostatic hyperplasia (benign enlargement of the prostate)
Bicytopenia (two parameters from the full blood count are low, the term bicytopenia can be used)
Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
Calcium metabolism disorder (occur when the body has too little or too much calcium)
Cardiac failure congestive

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 8 people, 53.33%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 6.67%
Depression: 1 person, 6.67%
Breast Cancer Metastatic: 1 person, 6.67%
Bipolar Disorder (mood disorder): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Cholestyramine and Demadex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously